Biolase Technology is now promoting deep pocket therapy (DPT) with new attachment using the Waterlase MD and patented radial firing perio tips (RFPT) as a non-surgical alternative treatment for moderate to advanced gum disease.
The newly FDA-cleared procedure for the Waterlase MD assists in new attachment, and in most cases provides deep pocket treatments in a single visit without the use of a scalpel, stitches, or the conventional cutting of the gums, the company said in a press release.
While treating deep pockets is considered critical for overall good health and the preservation of teeth, the invasive nature of the traditional procedure increases the anxiety many patients have for gum treatment, and many patients diagnosed with moderate to advanced pockets have avoided the procedure all together, Biolase said.
"We see patients every day that are seeking laser periodontal treatment. Both referring dentists and patients want to avoid swelling, pain, and possible gum recession of flap surgery," said Dr. Bret Dyer, a periodontist from Sugar Land, TX, and one of the key clinical researchers who has been working with the Waterlase MD for periodontal therapy for many years. "In my formal research and in clinical practice, I have found that DPT is a highly effective, more aesthetic, and more comfortable alternative to traditional surgical procedures for my patients."
In North America and many countries around the world, Biolase products are available exclusively through Henry Schein Dental.
"A key part of our new strategy has been to formalize more applications for specialists and general practitioners alike, with a primary focus on periodontal procedures due to the unique all-tissue capabilities of the Waterlase MD," said Biolase CEO David M. Mulder in the release. "This new FDA clearance, our patented Radial Firing Perio Tips, our new Periodontal Package for the Waterlase MD, and the advanced periodontal training in the package have greatly expanded our offerings to our doctors and their patients."